This company has been marked as potentially delisted and may not be actively trading. Jupiter Neurosciences (JUNS) Competitors Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsCompetitorsEarningsFDA EventsHeadlinesInsider TradesShort InterestTrendsBuy This Stock JUNS vs. SXTC, ACHV, AVTX, WGRX, PROF, TARA, CRBP, RCEL, PYXS, and SAVAShould you be buying Jupiter Neurosciences stock or one of its competitors? The main competitors of Jupiter Neurosciences include China SXT Pharmaceuticals (SXTC), Achieve Life Sciences (ACHV), Avalo Therapeutics (AVTX), Wellgistics Health (WGRX), Profound Medical (PROF), Protara Therapeutics (TARA), Corbus Pharmaceuticals (CRBP), Avita Medical (RCEL), Pyxis Oncology (PYXS), and Cassava Sciences (SAVA). These companies are all part of the "med - drugs" industry. Jupiter Neurosciences vs. Its Competitors China SXT Pharmaceuticals Achieve Life Sciences Avalo Therapeutics Wellgistics Health Profound Medical Protara Therapeutics Corbus Pharmaceuticals Avita Medical Pyxis Oncology Cassava Sciences China SXT Pharmaceuticals (NASDAQ:SXTC) and Jupiter Neurosciences (NASDAQ:JUNS) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, earnings, analyst recommendations, risk, valuation, dividends, media sentiment and institutional ownership. Which has higher valuation and earnings, SXTC or JUNS? Jupiter Neurosciences has lower revenue, but higher earnings than China SXT Pharmaceuticals. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioChina SXT Pharmaceuticals$1.74M131.96-$3.30MN/AN/AJupiter Neurosciences$230K230.18-$2.44MN/AN/A Is SXTC or JUNS more profitable? China SXT Pharmaceuticals' return on equity of 0.00% beat Jupiter Neurosciences' return on equity.Company Net Margins Return on Equity Return on Assets China SXT PharmaceuticalsN/A N/A N/A Jupiter Neurosciences N/A -835.24%-155.10% Does the media refer more to SXTC or JUNS? In the previous week, China SXT Pharmaceuticals had 1 more articles in the media than Jupiter Neurosciences. MarketBeat recorded 2 mentions for China SXT Pharmaceuticals and 1 mentions for Jupiter Neurosciences. China SXT Pharmaceuticals' average media sentiment score of 1.45 beat Jupiter Neurosciences' score of 0.94 indicating that China SXT Pharmaceuticals is being referred to more favorably in the media. Company Overall Sentiment China SXT Pharmaceuticals Positive Jupiter Neurosciences Positive Do institutionals & insiders have more ownership in SXTC or JUNS? 5.0% of China SXT Pharmaceuticals shares are held by institutional investors. 4.0% of China SXT Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Do analysts rate SXTC or JUNS? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score China SXT Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Jupiter Neurosciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 4.00 SummaryChina SXT Pharmaceuticals beats Jupiter Neurosciences on 7 of the 11 factors compared between the two stocks. Get Jupiter Neurosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for JUNS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding JUNS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart JUNS vs. The Competition Export to ExcelMetricJupiter NeurosciencesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$52.94M$2.59B$5.84B$10.14BDividend YieldN/A56.52%5.68%4.60%P/E Ratio-8.0023.8575.4125.98Price / Sales230.18529.66515.81181.13Price / CashN/A171.1637.5660.44Price / Book11.695.3712.156.29Net Income-$2.44M$32.95M$3.29B$271.07M Jupiter Neurosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)JUNSJupiter Neurosciences0.2314 of 5 stars$1.52-2.6%N/AN/A$52.94M$230K-8.005SXTCChina SXT Pharmaceuticals1.3002 of 5 stars$1.47-11.2%N/A-62.8%$174.63M$1.74M0.0090Positive NewsShort Interest ↓ACHVAchieve Life Sciences2.2349 of 5 stars$2.92-0.2%$14.67+401.8%-32.0%$148.50MN/A-1.9920News CoverageShort Interest ↑AVTXAvalo Therapeutics3.7871 of 5 stars$11.35-0.5%$30.00+164.3%+18.6%$148.14M$440K0.0040Short Interest ↓WGRXWellgistics HealthN/A$1.56-1.9%N/AN/A$131.13M$18.13M0.0031News CoverageAnalyst DowngradeGap DownPROFProfound Medical2.2083 of 5 stars$4.11flat$11.00+167.6%-47.7%$123.96M$10.68M-2.83150Positive NewsTARAProtara Therapeutics1.5535 of 5 stars$3.07-0.2%$19.60+539.5%+67.0%$118.25MN/A-1.8930Positive NewsCRBPCorbus Pharmaceuticals4.3977 of 5 stars$9.56-3.4%$49.00+412.7%-83.0%$117.62MN/A-2.0240Positive NewsRCELAvita Medical2.4756 of 5 stars$4.15-1.4%$11.60+179.5%-55.6%$111.01M$64.25M-2.12130PYXSPyxis Oncology2.7014 of 5 stars$1.80-8.2%$7.75+330.8%-51.9%$110.71M$16.15M-1.1260SAVACassava Sciences2.3226 of 5 stars$2.18+1.6%$2.00-8.0%-92.5%$105.07MN/A-0.8530Positive News Related Companies and Tools Related Companies SXTC Competitors ACHV Competitors AVTX Competitors WGRX Competitors PROF Competitors TARA Competitors CRBP Competitors RCEL Competitors PYXS Competitors SAVA Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:JUNS) was last updated on 9/14/2025 by MarketBeat.com Staff From Our PartnersTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredApple’s falling behindApple just posted record-breaking results, yet its stock barely moved — because in today’s market, investors o...Porter & Company | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredThe $17B signal no one expected…After SpaceX struck a $17 billion deal with EchoStar for a block of radio frequencies, tech analyst Jeff Brown...Brownstone Research | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Jupiter Neurosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Jupiter Neurosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free JUNS Stock Alerts